HomeCompareGHSI vs PLD

GHSI vs PLD: Dividend Comparison 2026

GHSI yields 615.38% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GHSI wins by $317090.34M in total portfolio value
10 years
GHSI
GHSI
● Live price
615.38%
Share price
$3.25
Annual div
$20.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$317096.84M
Annual income
$240,286,389,158.92
Full GHSI calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — GHSI vs PLD

📍 GHSI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGHSIPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GHSI + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GHSI pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GHSI
Annual income on $10K today (after 15% tax)
$52,307.69/yr
After 10yr DRIP, annual income (after tax)
$204,243,430,785.08/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, GHSI beats the other by $204,238,962,814.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GHSI + PLD for your $10,000?

GHSI: 50%PLD: 50%
100% PLD50/50100% GHSI
Portfolio after 10yr
$158551.67M
Annual income
$120,145,822,797.55/yr
Blended yield
75.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

GHSI
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$0.01
-99.6% upside vs current
Range: $0.01 — $0.01
Altman Z
-5.6
Piotroski
5/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GHSI buys
0
PLD buys
0
No recent congressional trades found for GHSI or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGHSIPLD
Forward yield615.38%3.18%
Annual dividend / share$20.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$317096.84M$6.50M
Annual income after 10y$240,286,389,158.92$5,256,436.18
Total dividends collected$310719.17M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$0.01$136.00

Year-by-year: GHSI vs PLD ($10,000, DRIP)

YearGHSI PortfolioGHSI Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$72,238$61,538.46$11,255$555.24+$61.0KGHSI
2$492,757$415,462.04$13,062$1,018.59+$479.7KGHSI
3$3,175,824$2,648,573.62$15,903$1,926.67+$3.16MGHSI
4$19,351,474$15,953,343.00$20,839$3,823.32+$19.33MGHSI
5$111,556,214$90,850,136.77$30,464$8,166.08+$111.53MGHSI
6$608,830,006$489,464,856.28$52,054$19,457.30+$608.78MGHSI
7$3,147,996,660$2,496,548,553.59$109,886$54,188.93+$3147.89MGHSI
8$15,432,443,240$12,064,086,814.21$304,030$186,451.18+$15432.14MGHSI
9$71,785,467,937$55,272,753,670.42$1,166,125$840,813.32+$71784.30MGHSI
10$317,096,839,852$240,286,389,158.92$6,504,190$5,256,436.18+$317090.34MGHSI

GHSI vs PLD: Complete Analysis 2026

GHSIStock

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Full GHSI Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this GHSI vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GHSI vs SCHDGHSI vs JEPIGHSI vs OGHSI vs KOGHSI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.